Any decision to use bupropion and Saxenda together must be made under the direct supervision of a qualified healthcare professional who can assess the individual risk-benefit profile and provide appropriate clinical oversight throughout treatment
Moreover, CNS GIPR KO and mGIPR-Ab/GLP-1 treatment of wild-type mice both result in reduced activity in pathways associated with immune function, particularly neutrophil degranulation, suggesting that decreased CNS GIPR signalling might reduce obesity-associated inflammation 47,48,49
This work was supported by the Japan Society for the Promotion of Science KAKENHI (21H04811 and 22K19405), AMED (JP23ek0109521), Daiichi Sankyo Foundation of Life Science, The NOVARTIS Foundation (Japan) for the Promotion of Science and G-7 Scholarship Foundation
Both medications suppress appetite through different pathways, creating potential for additive effects
doi: 10.1016/j.alcohol.2004.08.002
[I]n the population studied, several important variables such as intracranial pressure were not measured, Soh told Healthline
